1760.40 10.35 (0.59%)

84.13% Gain from 52W Low

55,036 NSE+BSE Volume

NSEJan 21, 2022 03:31 PM



1760.40
0.59%
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholding for the Period Ended December 31, 2021
BSE India
JB Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
1760.40
0.59%
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Statement Of Investor Complaints For The Quarter Ended December 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sandeep PhadnisDesignation :- Company Secretary and Compliance Officer
default
1760.40
0.59%
1760.40
0.59%
1760.40
0.59%
default
1760.40
0.59%
1760.40
0.59%
ICICI Securities Limited
JB Chemicals & Pharmaceuticals’ (JBCPL) Q2FY22 performance was better than estimates driven by strong growth in India business. EBITDA margin was lower than estimates owing to ESOPs charge. Consolidated revenue grew 33.7% YoY to Rs5.9bn and EBITDA margin dropped 340bps to 21.4%.
J B Chemicals & Pharmaceuticals Ltd. is trading above all available SMAs
1760.40
0.59%
Earnings Call for Q2FY22 of J B Chemicals & Pharmaceuticals
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
1760.40
0.59%
1760.40
0.59%
default
136 Votes:
Buy74.26%
Sell14.71%
Hold11.03%
BUY
SELL
HOLD